CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ries, C. R.
Right arrow Articles by Puil, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ries, C. R.
Right arrow Articles by Puil, E.

Canadian Journal of Anesthesia, Vol 41, 414-419, Copyright © 1994 by Canadian Anesthesiologists' Society


ARTICLES

Opisthotonos following propofol: a nonepileptic perspective and treatment strategy

CR Ries, PJ Scoates and E Puil
Department of Anaesthesia, University of British Columbia, Vancouver.

In this report of opisthotonos during recovery from propofol anaesthesia, we relate clinical observations with scientific considerations, and propose a strategy for treatment of this rare side effect. Following a brief operative procedure, a healthy 29-yr-old woman developed recurrent opisthotonos while recovering from anaesthesia with alfentanil, propofol, and nitrous oxide. In contrast to accumulating reports, the patient remained conscious during each episode of back extension and retrocollis. The preservation of consciousness and similarities to strychnine-induced opisthotonos suggest to us that the mechanism may have a brainstem and spinal origin. Recent investigations show that propofol potentiates the inhibitory transmitters glycine and gamma-aminobutyric acid (GABA) which would enhance spinal inhibition during anaesthesia. Postanaesthetic opisthotonos, however, may be due to a propofol-induced tolerance to inhibitory transmitters. This rebound phenomenon would lead to an acute, enduring refractoriness in inhibitory pathways of the brainstem and spinal cord, resulting in increased activity of extensor motoneurons. We recommend a therapeutic strategy that restores inhibition by glycine and GABA at multiple sites; the preferred therapeutic agents would be diazepam and physostigmine. The episodes are usually short-lived, but two of the reviewed 17 patients developed recurrent retrocollis for four and 23 days following antiepileptic drug therapy. Since high doses of phenytoin and carbamazepine can result in opisthotonos, we recommend that anticonvulsants be reserved for postanaesthetic patients with electroencephalographic evidence of seizure activity.


This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
S. Roy and L.-P. Fortier
Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine: [La rigidite induite par le fentanyl, pendant le retour a la conscience qui suit l'anesthesie generale, est potentialisee par la venlafexine]
Can J Anesth, January 1, 2003; 50(1): 32 - 35.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Walder, M. R. Tramer, and M. Seeck
Seizure-like phenomena and propofol: A systematic review
Neurology, May 14, 2002; 58(9): 1327 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. M. Schramm and B. A. Orser
Dystonic Reaction to Propofol Attenuated by Benztropine (Cogentin)
Anesth. Analg., May 1, 2002; 94(5): 1237 - 1240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Canadian Anesthesiologists' Society.